INTRODUCTION {#sec1-1}
============

Clayman and associates first described laparoscopic radical nephrectomy (LRN) at Washington University in June 1990.\[[@CIT1]\] The aim of laparoscopy has been to duplicate the principles of open radical nephrectomy (ORN) in terms of oncologic efficacy.\[[@CIT2]\] Recent reports suggest that LRN can be done with comparable oncologic outcomes even in larger tumors (Stage T2) as a surgeon ascends the learning curve.\[[@CIT2][@CIT3]\] We report our experience with LRN and compare the outcome with that of ORN in terms of safety, morbidity and oncologic outcome.

MATERIALS AND METHODS {#sec1-2}
=====================

Study population {#sec2-1}
----------------

The records of 65 patients who underwent LRN between January 2002 and December 2006 were compared with those of 56 patients who underwent ORN between January 2000 and December 2005. All patients had an ultrasound scan of the abdomen with a contrast-enhanced CT scan preoperatively. Metastatic workup included a chest radiograph and liver function tests. The patients were staged according to the International TNM Staging system for Renal cell carcinoma\[[@CIT4]\] and followed up accordingly.\[[@CIT5]\] Laparoscopic radical nephrectomy was performed by either a transperitoneal or a retroperitoneal approach. The criterion for selecting transperitoneal and reteroperitoneal approach was dependent on surgeon\'s preference.

Surgical technique {#sec2-2}
------------------

Transperitoneal LRN was performed using three or four ports. The dissection commenced by incising the white line of Toldt and reflecting the colon. The ureter was identified and lifted off the psoas muscle. The dissection proceeded outside Gerota\'s fascia toward the lower pole. The lumbar vein and adrenal vein were doubly clipped with Allport™ clips and cut. The renal vein was dissected free. The renal artery was bared and doubly secured with Hem-o-lok™ clips. Adrenalectomy was done in all upper-pole tumors and T2 lesions.\[[@CIT6]\] The specimen was retrieved through an incision in the right iliac fossa or a Pfannensteil incision.

Retroperitoneal LRN was done by creating a space at the tip of the 12^th^ rib with a combination of blunt and balloon dissection. The working port was placed at a point between the midaxillary line and the anterior axillary line (5 cm above the iliac crest). A 5-mm port was inserted at the junction of the 12^th^ rib and paraspinal muscles (renal angle). The dissection was kept outside Gerota\'s fascia and the renal vessels were clipped with Hem-o-lok clips.

Open radical nephrectomy was done employing a flank incision. All were done retroperitoneal. We do not perform lymphadenectomy.

Outcome analysis {#sec2-3}
----------------

The safety and efficacy of LRN was compared with the open technique. The parameters compared were operative room time (ORT), hematocrit drop, analgesia required, complications, hospitalization time and time to start of oral intake. The oncologic efficacy was evaluated by comparing local and distant recurrence, surgical margin status and survival using Kaplan-Meier analysis. The oncologic efficacy was compared separately for Stages T1, T2 and T3 using Student\'s t-test.

RESULTS {#sec1-3}
=======

In the laparoscopy group, 29 tumors were Stage T1, 18 were T2, while eight were T3. In the open surgery group, 25 tumors were Stage T1, 19 were T2 and 12 were T3. The staging was done clinically and confirmed on histopathology. The diagnosis of T3 lesions was based on clinical suspicion, confirmed on pathology. In our series the clinical diagnosis correlated with histopathology in 63% of patients in the laparoscopic group while in the open group it correlated in 42%. The two groups were comparable in terms of age, height, weight, BMI, specimen weight and size. Retrieval bag was used in the last 20 cases.

All four open conversions in the LRN group were in the first 30 cases. Three of them were attributable to difficulty in progression and one to renal vein bleeding. The complications in our series were comparable in both groups. The complications encountered in the LRN group were renal vein bleeding (n = 1), port site infection (n = 3), chest infection (n = 1) and subacute intestinal obstruction (n = 1).

The complications encountered in the ORN group were IVC injury (n = 1), wound infection (n = 1), Pneumothorax (n = 2) and Pleural injury (n = 1).

The laparoscopy group had a significantly shorter hospital stay, a lower analgesia requirement and less hemoglobin and hematocrit drop \[[Table 1](#T0001){ref-type="table"}\].

###### 

Characteristics of patients undergoing radical nephrectomy and operative data

                                          Laparoscopy         Open             *P* value
  --------------------------------------- ------------------- ---------------- ------------
  No. of patients                         65                  56               
  Mean age (years)                        52.96 (22-80)       52 (2-80)        0.38
  BMI                                     25.10 ± 4.58        24.45 ± 5.67     0.23
  M/F                                     50/15               43/13            
  Side (L/R)                              32/33               33/23            
  Mean ASA score                          1.75                2.00             0.49
  Mean OR time (min)                      179.50 (60-360)     158.6 (60-330)   0.02\*
  Hemoglobin drop (g/dL)                  1.55 (0.1-4.4)      2.25 (0.2-7)     0.001\*
  Hematocrit drop                         4.83 (0.3-12.9)     7.06 (2-18)      \<0.0001\*
  Specimen weight                         575.15 (120-1400)   583 (150-2500)   0.45
  Size                                    7.14 (2-17)         8.05 (3-18)      0.07
  Mean analgesia (mg of tramadol)         175.65 (50-550)     236 (0-1100)     0.03\*
  Mean hospital stay (days)               5.72 (3-23)         9.18 (4-23)      \<0.0001\*
  Mean time to start of oral intake (h)   24.7 (20-48)        29.2 18-120)     0.02\*

Demographic profile

There was no difference in the outcome of T1 and T2 lesions \[[Table 2](#T0002){ref-type="table"}\].

###### 

Comparison of results for T1 and T2 tumors (Laparoscopy group)

                                          T1                 T2                  *P* value
  --------------------------------------- ------------------ ------------------- ------------
  No. of patients                         29                 18                  
  Mean age (years)                        51.66 (22-75)      55.22 (30-80)       0.20
  BMI                                     25.13 ± 3.74       23.81 ± 5.07        0.16
  M/F                                     22/7               15/3                
  Side (L/R)                              9/20               13/5                
  Mean ASA                                1.79               1.70                0.49
  Mean OR time                            168.44 (60-300)    187.94 (120-360)    0.13
  Hemoglobin drop (g/dL)                  1.46 (0.1-2)       1.84 (0.3-4.4)      0.06
  Hematocrit drop                         4.61 (0.3-7)       5.65 (1-10.9)       0.08
  Specimen weight (g)                     455.13 (120-910)   748.33 (366-1400)   \<0.0001\*
  Size (cm)                               4.79 ± 1.29        10.26 ± 2.5         \<0.0001\*
  Mean analgesia (mg of tramadol)         167.5 (50-550)     164.7 (50-450)      0.47
  Mean hospital stay (days)               5.55 (3-23)        5.58 (3-12)         0.48
  Mean time to start of oral intake (h)   22.7 ± 2.33        26 ±7.41            0.02\*

Comparative analysis

Twenty-three per cent of patients (n = 15) received blood transfusions in the LRN group and 41% (n = 23) of patients in the ORN group required a blood transfusion. Hemoglobin assessment was done at 48 h postoperatively.

The oncologic efficacy was evaluated by comparing local and distant recurrence, surgical margin status and survival using Kaplan-Meier analysis. The cancer-free survival rate at 24 months for ORN and LRN in T1 lesions was 91.7% and 93.15%, respectively and the patient survival rate was 100% in both groups. The cancer-free survival rate at 24 months for ORN and LRN in T2 lesions was 88.9% and 94.1%, respectively. The patient survival rate was 100% and 94%, respectively. The cancer-free survival rate at 24 months for ORN and LRN in T3 lesions was 66.7% and 62.5%, respectively and the patient survival was 83.3% and 75%, respectively \[Figures [1](#F0001){ref-type="fig"}, [2](#F0002){ref-type="fig"}\].

![Kaplan Meier analysis of patient survival for open versus laparoscopic approach in T1, T2, T3 tumours](IJU-24-39-g001){#F0001}

![Kaplan Meier analysis of cancer free survival for open versus laparoscopic approach in T1, T2, T3 tumours](IJU-24-39-g002){#F0002}

One of the patients had all three types of recurrences i.e. local, port site and distant metastases, while one patient had local metastases and another had distant metastases \[[Table 3](#T0003){ref-type="table"}\].

###### 

Local and distant recurrences

  ----------------------- ----------- ----------------------------------------------------- -------------------- -------------------- ---------------------- --------------------
  **Laparoscopy group**                                                                                                                                      
                                                                                                                                                             
  Case No.                Size (cm)   Histopathology                                        Time to recurrence   Type of recurrence                          
                                                                                                                                                             
                                                                                                                 Local recurrence     Port site metastases   Distant metastases
                                                                                                                                                             
  26                      4 × 4       Papillary RCC, capsule infiltrated                    Two years            Yes                  Yes                    Yes
  39                      9 × 4       Well-differentiated, sarcomatoid changes              Eight months         Yes                  No                     No
  59                      10 × 4      Focal sarcomatoid diff; 60% tumor necrotic, grade 3   Two months           No                   No                     Yes
  ----------------------- ----------- ----------------------------------------------------- -------------------- -------------------- ---------------------- --------------------

  ---------------- --------------- ------------- ------------------------- ------------------------ --------------------------------
  **Open group**                                                                                    
                                                                                                    
  **Case No.**     **Size (cm)**   **Margins**   **Histopathology**        **Time to recurrence**   **Type of recurrence**
                                                                                                    
  2                7 × 6           Negative      Papillary RCC             Three months             Pulmonary metastases
  14               6 × 6           Negative      Squamous cell carcinoma   18 months                Pulmonary mets
  23               6 × 4           Negative      Squamous cell carcinoma   24 months                Pulmonary mets with nodal mets
  ---------------- --------------- ------------- ------------------------- ------------------------ --------------------------------

The upper size limit for LRN has been considered to be 13 cm.\[[@CIT4]\] We have operated on a lesion of 15 cm. As our experience increased, the acceptable specimen size went on increasing and simultaneously the conversion rate decreased \[[Table 4](#T0004){ref-type="table"}\].

###### 

Impact of experience on laparoscopic radical nephrectomy

                            1-10    11-20   21-30   31-40   41-50   51-60   61 till date
  ------------------------- ------- ------- ------- ------- ------- ------- --------------
  Number                    10      10      10      10      10      10      5
  Operating time (min)      175.7   169     143.3   165     184.5   212.5   224
  Hb drop (g%)              1.9     1.4     1.8     1.4     1.3     1.7     1.1
  PCV drop                  6.5     4.7     6.5     4.1     3.7     5.0     2.6
  Specimen weight (kg)      511     419     563     632     542.6   709.8   722.2
  Tumor size (cm)           6.5     6.05    7.8     7.6     5.9     8.9     7.4
  Analgesia (mg)            168.7   109     105     250     210     145     320
  Time to oral intake (h)   27      23.1    25.8    25.4    24.6    23.4    23.6
  Hospital stay (days)      4.75    7.2     3.8     5.3     4.9     7.3     7.0
  Complications                                                             
   Minor                    1       \-      1       \-      \-      \-      \-
   Major                    1       1               1       \-      \-      \-
   Conversion               2       1       1       1       \-      \-      \-

DISCUSSION {#sec1-4}
==========

Laparoscopic radical nephrectomy is now a widely practiced and accepted treatment modality for T1 lesions.\[[@CIT2]\] The aim of laparoscopy has been to duplicate the principles of open radical nephrectomy (ORN) in terms of oncologic efficacy.\[[@CIT2]\]

Initial studies relied on the surgical margin status and the specimen weight to assess oncologic efficacy. These studies suggested that the specimen weight should be equivalent to preoperative size or 20% less if removed by morcellation.\[[@CIT7]\] In our study, the specimen weight was equivalent to that of ORN. The margins were positive in two cases, one in a patient with T3A disease and the other in a patient with T3B disease. Our experience suggests that renal vein involvement and IVC involvement are technically more challenging and increase the chance of conversion and recurrence. We feel that T3 tumors with only perinephric involvement can be selected for laparoscopic approach.

Local recurrence is defined as evidence of recurrent disease in the renal fossa.\[[@CIT8][@CIT9]\] Portis and associates\[[@CIT8]\] demonstrated five-year recurrence-free survival and cancer-specific survival rates of 92% and 96%, respectively. Although the follow-up is short our study shows similar results on cancer-specific and patient survival at 24 months \[Figures [1](#F0001){ref-type="fig"}, [2](#F0002){ref-type="fig"}\]. One of the patients had all three types of recurrences i.e. local, port site and distant metastases, while there was one instance of local metastases and a distant metastases. All recurrences after ORN were distant \[[Table 3](#T0003){ref-type="table"}\].

In urology, initial reports of port-site recurrence followed laparoscopic lymphadenectomy for carcinoma of the prostate or bladder.\[[@CIT10]\] The measures suggested to reduce port-site recurrence are use of a bag for intact removal of specimen and appropriate precautions before morcellation such as redraping and irrigating to prevent tumor contamination.\[[@CIT11]\] Dhobada *et al.*, have reported a port-site recurrence eight months after LRN for a T2N0M0 RCC. The specimen was retrieved by an Endocatch bag.\[[@CIT12]\] A recent report highlights the role of tumor and host biology in port-site metastasis.\[[@CIT13]\] In our series, we had one instance of port-site recurrence. The specimen in this case was retrieved by manual extraction. The patient presented with a lump at the site of the 11-mm port.

As surgeons ascend the learning curve, they become comfortable operating on large tumors. The upper size limit for LRN has been considered to be 13 cm.\[[@CIT8][@CIT14]\] We have operated on a lesion of 15 cm. As our experience increased, the acceptable specimen size went on increasing and simultaneously the conversion rate decreased. The stay was longer as the majority of patients were traveling from long distance and the patient had longer stay on request. Moreover as our experience increased we have been operating on larger tumors and hence the longer stay \[[Table 4](#T0004){ref-type="table"}\].

Although it is not done at our institute, specimen morcellation has been practiced at other centers, the cited advantage being less pain, faster convalescence and shorter incisions. The perceived disadvantages are difficulties in histopathologic analysis and the risk of tract seeding.\[[@CIT15]\] In our series, we retrieved the specimen intact and since we had the instance of port-site metastasis, we removed the specimen with a homemade bag.

Whether one uses a transperitoneal or a retroperitoneal approach generally depends on surgeon preference and comfort level. When performed in accordance with oncologic principles such as early control of the renal hilum and en bloc dissection of the kidney outside Gerota\'s fascia, the outcomes of both should be comparable. The advantages of the transperitoneal approach include familiarity of the anatomy and a good working space. The disadvantages include the need to reflect the abdominal structures. The retroperitoneal approach offers rapid access to the hilum and avoidance of the peritoneal cavity. In theory, this should reduce the incidence of postoperative ileus and injury to intraperitoneal contents.\[[@CIT16]\] The majority of our LRNs have been done with the transperitoneal approach, as we are comfortable with it.

CONCLUSION {#sec1-5}
==========

Laparoscopic radical nephrectomy has advantages in terms of shorter hospitalization and a lower analgesia requirement. It is feasible and produces effective cancer control in T1 lesions, comparable to that of its open counterpart in T2 and selected cases of T3 lesions. Reports of port-site metastasis mandate a multicenter analysis.
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